Kristin Roshelli is a partner in King & Spalding’s Houston Healthcare practice. Kristin’s practice focuses on corporate and regulatory matters in the healthcare and life sciences industries.  She represents healthcare investors and a broad range of prominent healthcare clients on mergers and acquisitions, affiliations, general health law questions, and complex corporate governance and contracting matters. She is also a go-to lawyer for leading pharmaceutical, biotech, organ procurement and other large companies for assistance with complex collaboration arrangements with third parties and in establishing and negotiating their supply chain and other key contracts.  Her work often involves advising on international product supply agreements, product manufacturing and supply agreements, licensing arrangements, commercialization and distribution services agreements, specialty pharmacy agreements, research agreements and other complex collaboration arrangements and key service and supply contracts. 

She is Chambers-ranked for healthcare in Texas and has been recognized by Legal 500 as a “Recommended Key Lawyer,” by Texas Super Lawyers as a healthcare rising star, and by Texas Lawyers with an “On the Rise Award,” which recognizes lawyers under the age of 40 who have wielded influence in their practice areas in Texas and beyond.  Prior to entering the legal field, Kristin served as a nurse in the United States Air Force, worked in the general counsel’s office of a large academic medical center, and practiced as a registered nurse in a medical intensive care unit. 

Publications

• 2016 Health Care Fraud and Abuse Top Ten List Reimbursement Advisor, Vol 32, No. 6, February 2017
• “The Plot Thickens for the Medicare Narrative Requirement,” Law360, February 2015
• “When is a Hospital a ‘New Hospital?,’” Reimbursement Advisor, Vol. 30, No. 4, December 2014

Back to Page